Comparative Efficacy Of Intraductal Antibiotic During ERCP In Acute Cholangitis

Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age18+
SponsorNational University of Malaysia

About this trial

Does intraductal administration of antibiotics during endoscopic retrograde cholangiopancreatography (ERCP), in addition to standard systemic antibiotic therapy, improve clinical outcomes in patients with acute cholangitis compared with standard systemic antibiotic therapy alone?

Eligibility criteria

Qualifiers

The patients diagnosed with mild and moderate acute cholangitis based on TG 18

Planned for ERCP within 48 hours

18 years old and above

Disqualifiers

Severe acute cholangitis

History of antibiotic hypersensitivity

Receiving cancer chemotherapy, steroids, or immunosuppressive agents

Concomitant infections

Trial design

Treatments tested in this trial

  • Gentamicin - single dose
  • Distilled water

Treatment groups

172 Participants
are divided into 2 treatment groups

Locations

1

Map coordinates are unavailable for these locations. Locations are shown below instead.

Hospital Canselor Tuanku Muhriz UKMRecruiting56000, Cheras, Kuala LumpurMalaysiaMalaysia